Myocarditis and pericarditis
What public evidence exists on this topic, and what kind of evidence each piece is. Each section is a different kind of evidence from a different system; the numbers are never added together.
VAERS reports Adverse-event report (unverified)
- 3,280 COVID-19 vaccine reports listing myocarditis rows
- 2,307 COVID-19 vaccine reports listing pericarditis rows
- 141 COVID-19 vaccine reports listing myopericarditis rows
- myocarditis
- pericarditis
- myopericarditis
VAERS reports are unverified, have no denominator, and do not show that a vaccine caused anything. One report can list several terms, so terms overlap.
V-safe structured check-ins Self-reported health event
V-safe's check-the-box questions recorded general categories (symptoms, missed work, medical care, hospitalization), not specific conditions, so they hold no myocarditis and pericarditis-specific counts. See Safety Data for the category counts.
V-safe narratives Self-reported health event
The narrative index is not available yet.
FDA and CDC findings and actions Regulatory signal / recognized adverse reaction
- Recognized adverse reaction FDA adds a myocarditis and pericarditis warning to Pfizer and Moderna fact sheets Superseded
FDA revised both mRNA vaccines' fact sheets after ACIP reviewed reports suggesting increased risks of myocarditis and pericarditis, particularly after the second dose and with onset within a few days. - Recognized adverse reaction Novavax vaccine authorized with a myocarditis and pericarditis warning Current
The Novavax fact sheet warns that clinical-trial data provide evidence for increased risks of myocarditis and pericarditis; six cases were detected among 41,546 trial recipients aged 16 and older. - Recognized adverse reaction FDA requires updated myocarditis and pericarditis warning for mRNA COVID-19 vaccines Current
FDA approved required labeling changes adding an estimated unadjusted incidence of myocarditis and/or pericarditis after the 2023–2024 formula of mRNA COVID-19 vaccines — about 8 cases per million doses in people 6 months through 64 years old, and about 27 cases per million doses in males 12 through 24 — and results of a cardiac MRI study in which abnormal findings often persisted at about five months.
Compensation (CICP) Compensation claim / claim compensated
- 649 CICP COVID-19 vaccine claims whose alleged injury text mentions this topic (as of Jul 1, 2026) rows
- 35 compensated COVID-19 vaccine claims for this covered injury, $553,162 paid (as of Mar 1, 2026) rows
Claims are allegations; a payment is a program determination under CICP rules, not a scientific finding. COVID-19 vaccines are not covered by the VICP.
Litigation Lawsuit allegation
- Florida v. Pfizer Inc. and Albert Bourla (COVID-19 vaccine marketing) pending
- Kansas v. Pfizer Inc. (COVID-19 vaccine marketing) on appeal
Allegations in a complaint are not findings.
Studies and public records Epidemiologic association / public record
No study or public record on this topic has been added yet.